Morphosys (MOR) has released an update.
MorphoSys AG, a biopharmaceutical company based in Planegg, Germany, has issued a voting rights announcement following the acquisition of equity collateral. The notification shows that DWS Investment GmbH now holds a total of 3.70% of the voting rights as of April 12, 2024. This change marks a significant increase from the previous notification, reflecting a new distribution of voting power within the company.
For further insights into MOR stock, check out TipRanks’ Stock Analysis page.
